Cleared Traditional

K223620 - Reprieve by RegenesisTM

K223620 is an FDA 510(k) clearance for Reprieve by RegenesisTM, manufactured by Regenesis Biomedical, Inc.. The device is a Class 2 Physical Medicine device with product code IMJ cleared through the Traditional 510(k) pathway after a 170-day FDA review.

K223620 · Regenesis Biomedical, Inc. · Physical Medicine device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2023
Decision
170d
Days
Class 2
Risk

K223620 is an FDA 510(k) clearance for the Reprieve by RegenesisTM. Classified as Diathermy, Shortwave, For Use In Applying Therapeutic Deep Heat (product code IMJ), Class II - Special Controls.

Submitted by Regenesis Biomedical, Inc. (Scottsdale, US). The FDA issued a Cleared decision on May 24, 2023 after a review of 170 days - an extended review cycle.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5290 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.

View all Regenesis Biomedical, Inc. devices

FDA 510(k) Submission Details - K223620

510(k) Number K223620 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 05, 2022
Decision Date May 24, 2023
Days to Decision 170 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
55d slower than avg
Panel avg: 115d · This submission: 170d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IMJ Device Classification - Class 2, Special Controls

Product Code IMJ Diathermy, Shortwave, For Use In Applying Therapeutic Deep Heat
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 890.5290
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Physical Medicine devices follow this clearance model.

Regulatory Peers - IMJ Diathermy, Shortwave, For Use In Applying Therapeutic Deep Heat

All 18
Devices cleared under the same product code (IMJ) and FDA review panel - the closest regulatory comparables to K223620.
BTL-899TT
K252963 · BTL Industries, Inc. · Jun 2026
ViVY
K250376 · Viatherm Therapeutics, LLC · Nov 2025
Curapuls 670
K243112 · Enraf-Nonius, B.V. · Jun 2025
BTL-703
K182363 · BTL Industries, Inc. · Jan 2019
ViaTherm BOOST
K173300 · Viatherm Therapeutics, LLC · May 2018
SW-THERM
K131899 · Shenzhen Dongdixin Technology Co., Ltd. · Mar 2014